Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in Vero cells

Journal of Medical Virology

Volumn 82, Issue 5, 2010, Pages 817-824

  Khan, Mohsin ^a   Santhosh, S R ^a   Tiwari, Mugdha ^a   Lakshmana Rao, P V ^a   Parida, Manmohan ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Chikungunya; Chloroquine; Virus inhibition

Indexed keywords

CHLOROQUINE; VIRUS RNA;

ARTICLE; CELL VIABILITY; CHIKUNGUNYA ALPHAVIRUS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; INTERNALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VERO CELL; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CHIKUNGUNYA VIRUS; CHLOROQUINE; PLAQUE ASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VERO CELLS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

CHIKUNGUNYA VIRUS;

EID: 77950997597     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21663     Document Type: Article

References (23)

1. Cassell S, Edwards J, Brown DT. 1984. Effects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus. J Virol 52:857-864. (Pubitemid 15216311)
2. Charell RN, de Lamballrie X, Raoult D. 2007. Chikungunya outbreaks-the globalization of vector borne diseases. N Engl J Med 356:769-771. (Pubitemid 46294608)
3. Charmot G, Coulaud JP. 1990. Treatment of Plasmodium falciparum malaria in Africa (except cerebral malaria). MedTrop 50:103-108. (Pubitemid 20165539)
4. Dash PK, Parida MM, Santhosh SR, Verma SK, Tripathi NK, Ambuj S, Saxena P, Gupta N, Chaudhary M, Babu JP, Lakshmi V, Mamidi N, Subhalaxmi MV, Lakshmana Rao PV, SekharK. 2007. East Central South African genotype as the causative agent in reemergence of Chikungunya outbreak in India. Vector Borne Zoonotic Dis 7:519-527.
5. Dash PK, Tiwari M, Santhosh SR, ParidaM, Lakshmana Rao PV. 2008. RNA interference mediated inhibition of Chikungunya virus replication in mammalian cells. Biochem Biophys Res Commun 376:718-722.
6. DeTulleo L, Kirchhausen T. 1998. The clathrin endocytic pathway in viral infection. EMBO J 17:4585-4593. (Pubitemid 28377159)
7. Finter NB. 1969. Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays. J Gen Virol 5: 419-427.
8. Gilbert BE, Knight V. 1986. Biochemistry and clinical application of ribavirin. Antimicrob Agents Chemother 30:201-205.
9. Jupp PG, McIntosh BM. 1998. Chikungunya virus disease. In: Monath TP, editor. The Arboviruses: Epidemiology and ecology. Boca Raton, FL: CRC press. pp 137-157.
10. Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M. 2004. In vitro inhibition of severe acute respiratory syndrome coronavirus by Chloroquine. Biochem Biophys Res Commun 323:264-268.
11. Kouroumalis EA, Koskinas J. 1986. Treatment of chronic active hepatitis B (CAH B) with Chloroquine: A preliminary report. Ann Acad Med Singapore 15:149-152. (Pubitemid 16091541)
12. Mavalankar D, Shastri P, Raman P. 2007. Chikungunya epidemic in India: A major public-health disaster. Lancet Infect Dis 7:306-307. (Pubitemid 46613867)
13. Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. 2007. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 7:319-327.
14. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Dottori M, Ciufolini MG, Majori GC, Cassone A. 2007. Infection with Chikungunya virus in Italy: An outbreak in a temperate region. Lancet 370:1840-1846.
15. Santhosh SR, Parida MM, Dash PK, Pateriya A, Pattnaik B, Pradhan HK, Tripathi NK, Srivastava A, Gupta N, Saxena P, Lakshmana Rao PV. 2007. Development and evaluation of SYBR Green I based one step real time RT-PCR assay for detection and quantification of Chikungunya virus. J Clin Virol 39:188-193.
16. Santhosh SR, Dash PK, Parida MM, Khan M, Tiwari M, Lakshmana Rao PV. 2008. Comparative full genome analysis revealed A226V shift in 2007 Indian Chikungunya virus isolates. Virus Res 135:36-41.
17. Savarino A. 2005. Expanding the frontiers of existing antiviral drugs: Possible effects of HIV-1 protease inhibitors against SARS and avian influenza. J Clin Virol 34:170-178. (Pubitemid 41427312)
18. Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. 2003. Effects of chloroquine on viral infections: An old drug against today's diseases? Lancet Infect Dis 3:722-727.
19. Savarino A, Trani LD, Donatelli I, Cauda R, Cassone A. 2006. New insights into the antiviral effects of Chloroquine. Lancet Infect Dis 6:67-69. (Pubitemid 43138901)
20. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F, Biscornet L, Diancourt L, Michel S, Duquerroy S, Guigon G, Frenkiel MP, Bréhin AC, Cubito N, Desprès P, Kunst F, Rey FA, Zeller H, Brisse S. 2006. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 3:e263.
21. Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, Sol-Foulon N, Roux KL, Prevost MC, Fsihi H, Frenkiel MP, Blanchet F, Afonso PV, Ceccaldi PE, Ozden S, Gessain A, Schuffenecker I, Verhasselt B, Zamborlini A, Saïb A, Rey FA, Arenzana-Seisdedos F, Desprès P, Michault A, Albert ML, Schwartz O. 2007. Characterization of reemerging chikungunya virus. PLoS Pathog 3:e89.
22. Tsai WP, Nara PL, Kung HF, Oroszlan S. 1990. Inhibition of human immunodeficiency virus infectivity by chloroquine. AIDS Res Hum Retroviruses 6:481-489.
23. Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, SeidahNG, Nichol ST. 2005. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2:69.